Stay updated on Daratumumab in AL Amyloidosis Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in AL Amyloidosis Clinical Trial page.

Latest updates to the Daratumumab in AL Amyloidosis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now marks recruitment as closed, indicating that no new participants will be enrolled.SummaryDifference0.2%

- Check18 days agoChange Detected**Revision tag updated**: The page now displays Revision: v3.5.5, replacing v3.5.4. This signals a new build of the page and may include minor fixes or updates, while the study details remain unchanged.SummaryDifference0.0%

- Check40 days agoChange DetectedA new Blood publication citation for ANDROMEDA survival analysis was added to the Publications section, and the page revision history shows an update to v3.5.4 from v3.5.3.SummaryDifference0.0%

- Check61 days agoChange DetectedThe ClinicalTrials.gov page’s displayed revision/version number was updated from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check97 days agoChange DetectedRevision: v3.5.0 deployed, replacing v3.4.3. No user-facing changes to the study details or core content.SummaryDifference0.0%

- Check111 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be metadata only and does not change study content or user-facing functionality.SummaryDifference0.0%

Stay in the know with updates to Daratumumab in AL Amyloidosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in AL Amyloidosis Clinical Trial page.